Technology
Health
Biotechnology

aTyr Pharma

$3.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (4.27%) Today
+$0.08 (2.76%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell aTyr Pharma and other stocks, options, ETFs, and crypto commission-free!

About LIFE

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. Read More The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Employees
42
Headquarters
San Diego, California
Founded
2005
Market Cap
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
49.85K
High Today
$3.09
Low Today
$2.76
Open Price
$2.80
Volume
82.37K
52 Week High
$12.33
52 Week Low
$2.76

Collections

Technology
Health
Biotechnology
Therapy
2015 IPO
US
North America

LIFE Earnings

-$2.74
-$1.89
-$1.03
-$0.18
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$2.74 per share
Actual
-$1.80 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.